Literature DB >> 26976638

Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Chanèle Cyr-Depauw1, Jason J Northey1, Sébastien Tabariès2, Matthew G Annis2, Zhifeng Dong2, Sean Cory3, Michael Hallett3, Jonathan P Rennhack4, Eran R Andrechek4, Peter M Siegel5.   

Abstract

ShcA is an important mediator of ErbB2- and transforming growth factor β (TGF-β)-induced breast cancer cell migration, invasion, and metastasis. We show that in the context of reduced ShcA levels, the bone morphogenetic protein (BMP) antagonist chordin-like 1 (Chrdl1) is upregulated in numerous breast cancer cells following TGF-β stimulation. BMPs have emerged as important modulators of breast cancer aggressiveness, and we have investigated the ability of Chrdl1 to block BMP-induced increases in breast cancer cell migration and invasion. Breast cancer-derived conditioned medium containing elevated concentrations of endogenous Chrdl1, as well as medium containing recombinant Chrdl1, suppresses BMP4-induced signaling in multiple breast cancer cell lines. Live-cell migration assays reveal that BMP4 induces breast cancer migration, which is effectively blocked by Chrdl1. We demonstrate that BMP4 also stimulated breast cancer cell invasion and matrix degradation, in part, through enhanced metalloproteinase 2 (MMP2) and MMP9 activity that is antagonized by Chrdl1. Finally, high Chrdl1 expression was associated with better clinical outcomes in patients with breast cancer. Together, our data reveal that Chrdl1 acts as a negative regulator of malignant breast cancer phenotypes through inhibition of BMP signaling.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26976638      PMCID: PMC4859683          DOI: 10.1128/MCB.00600-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  BMP2 promotes migration and invasion of breast cancer cells via cytoskeletal reorganization and adhesion decrease: an AFM investigation.

Authors:  Hua Jin; Jiang Pi; Xun Huang; Feicheng Huang; Wenxiang Shao; Shengpu Li; Yong Chen; Jiye Cai
Journal:  Appl Microbiol Biotechnol       Date:  2012-01-21       Impact factor: 4.813

Review 2.  Signaling inputs to invadopodia and podosomes.

Authors:  Daisuke Hoshino; Kevin M Branch; Alissa M Weaver
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

3.  A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages.

Authors:  N Nakayama; C E Han ; S Scully; R Nishinakamura; C He; L Zeni; H Yamane; D Chang; D Yu; T Yokota; D Wen
Journal:  Dev Biol       Date:  2001-04-15       Impact factor: 3.582

4.  Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

Authors:  Johanna M Ketolainen; Emma-Leena Alarmo; Vilppu J Tuominen; Anne Kallioniemi
Journal:  Breast Cancer Res Treat       Date:  2010-02-25       Impact factor: 4.872

5.  A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

Authors:  Emma-Leena Alarmo; Tuula Kuukasjärvi; Ritva Karhu; Anne Kallioniemi
Journal:  Breast Cancer Res Treat       Date:  2006-09-21       Impact factor: 4.872

6.  BMP7 influences proliferation, migration, and invasion of breast cancer cells.

Authors:  Emma-Leena Alarmo; Jenita Pärssinen; Johanna M Ketolainen; Kimmo Savinainen; Ritva Karhu; Anne Kallioniemi
Journal:  Cancer Lett       Date:  2008-11-05       Impact factor: 8.679

7.  Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.

Authors:  Shizhen Emily Wang; Bin Xiang; Marta Guix; Maria Graciela Olivares; Joel Parker; Christine H Chung; Atanasio Pandiella; Carlos L Arteaga
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

8.  A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.

Authors:  Elaine Ngan; Jason J Northey; Claire M Brown; Josie Ursini-Siegel; Peter M Siegel
Journal:  J Cell Sci       Date:  2013-02-27       Impact factor: 5.285

9.  Talin regulates moesin-NHE-1 recruitment to invadopodia and promotes mammary tumor metastasis.

Authors:  Brian T Beaty; Yarong Wang; Jose Javier Bravo-Cordero; Ved P Sharma; Veronika Miskolci; Louis Hodgson; John Condeelis
Journal:  J Cell Biol       Date:  2014-06-02       Impact factor: 10.539

10.  Inhibition of BMP signaling suppresses metastasis in mammary cancer.

Authors:  P Owens; M W Pickup; S V Novitskiy; J M Giltnane; A E Gorska; C R Hopkins; C C Hong; H L Moses
Journal:  Oncogene       Date:  2014-07-07       Impact factor: 9.867

View more
  21 in total

1.  Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development.

Authors:  Katarzyna Lubecka; Kirsty Flower; Megan Beetch; Jay Qiu; Lucinda Kurzava; Hannah Buvala; Adam Ruhayel; Samer Gawrieh; Suthat Liangpunsakul; Tracy Gonzalez; George McCabe; Naga Chalasani; James M Flanagan; Barbara Stefanska
Journal:  Epigenetics       Date:  2018-07-30       Impact factor: 4.528

2.  Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells.

Authors:  Chenxi Tian; Karl R Clauser; Daniel Öhlund; Steffen Rickelt; Ying Huang; Mala Gupta; D R Mani; Steven A Carr; David A Tuveson; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

3.  Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5.

Authors:  Ye Sun; Kun Yan; Yi Wang; Cheng Xu; Dan Wang; Wei Zhou; Shuning Guo; Yujie Han; Lei Tang; Yanqiu Shao; Shaobo Shan; Qiangfeng C Zhang; Yujie Tang; Liwei Zhang; Qiaoran Xi
Journal:  Nat Cancer       Date:  2022-08-01

4.  The Long-Term Stability of Intracortical Microstimulation and the Foreign Body Response Are Layer Dependent.

Authors:  Morgan E Urdaneta; Nicolas G Kunigk; Seth Currlin; Francisco Delgado; Shelley I Fried; Kevin J Otto
Journal:  Front Neurosci       Date:  2022-06-13       Impact factor: 5.152

5.  Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.

Authors:  Huan Deng; Qingqing Hang; Dijian Shen; Yibi Zhang; Ming Chen
Journal:  Cancer Cell Int       Date:  2021-05-12       Impact factor: 5.722

Review 6.  The Dual Role of Bone Morphogenetic Proteins in Cancer.

Authors:  Duc-Hiep Bach; Hyen Joo Park; Sang Kook Lee
Journal:  Mol Ther Oncolytics       Date:  2017-10-24       Impact factor: 7.200

7.  Transcriptome analysis revealed the possible regulatory pathways initiating female geese broodiness within the hypothalamic-pituitary-gonadal axis.

Authors:  Hehe Liu; Jiwen Wang; Liang Li; Chunchun Han; Hua He; Hengyong Xu
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

8.  Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.

Authors:  Elham Amjad; Solmaz Asnaashari; Babak Sokouti; Siavoush Dastmalchi
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

9.  Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset.

Authors:  Xue Wang; Chundi Gao; Fubin Feng; Jing Zhuang; Lijuan Liu; Huayao Li; Cun Liu; Jibiao Wu; Xia Zheng; Xia Ding; Changgang Sun
Journal:  Biomed Res Int       Date:  2020-07-24       Impact factor: 3.411

10.  Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.

Authors:  Yujie Shen; Shikun Dong; Jinhui Liu; Liqing Zhang; Jiacheng Zhang; Han Zhou; Weida Dong
Journal:  Biomed Res Int       Date:  2020-04-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.